Use these to boost your biotech exposure

Biotechnology companies have been at the forefront of some of the most exciting developments in healthcare over the past two decades—and there are more developments in the pipeline. However, the high cost of product development, long lead times for product testing and regulatory approvals, and… Read More

Q: Hi, Pat and team. I have seen some interesting industry comments on Procore Technologies lately. What’s your view on this stock as a buy? Thanks in advance.

A: Procore Technologies Inc., $62.68, symbol PCOR on New York (Shares outstanding: 142.4 million; Market cap: $8.9 billion; www.procore.com) is a leading provider of cloud-based construction management software.

Procore’s software platform aims to let all parties in a construction project communicate with each other online, share… Read More

Risks and rewards within the healthcare sector

Demand for healthcare products and services has been growing for decades—and this will continue as the population of the developed world grows older and medical services expand. Significant new developments in the field of medical technology and innovation will further boost the demand for medical… Read More

Q: Pat, can you give me your recommendation for Veeva Systems? It seems to have a good software niche. Thanks.

A: Veeva Systems Inc., $202.85, symbol VEEV on New York (Shares outstanding: 145.7 million; Market cap: $32.3 billion; www.veeva.com), is a provider of cloud-based customer relationship management (CRM) software for the life sciences, cosmetics and consumer-products industries.

The San Francisco-based company has more than 1,350 customers,… Read More